Table 3.
Asymptomatic cardiovascular impairment | Unadjusted | Adjusted* | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Cardiac abnormality | ||||
LVH | 1.664 (1.334–2.075) | <0.001 | 1.521 (1.213–1.909) | <0.001 |
LV diastolic dysfunction | 1.904 (1.410–2.571) | <0.001 | 1.736 (1.279–2.356) | <0.001 |
Macrocirculatory abnormality | ||||
Arteriosclerosis | 2.278 (1.660–3.127) | <0.001 | 2.360 (1.699–3.279) | <0.001 |
Atherosclerosis | 1.031 (0.855–1.243) | 0.752 | 1.040 (0.860–1.258) | 0.685 |
Microcirculatory abnormality | ||||
Microalbuminuria | 1.602 (1.338–1.918) | <0.001 | 1.566 (1.304–1.879) | <0.001 |
The ORs and 95% CI were calculated to estimate the associations of various cardiovascular impairments with MS by using binary logistic regression models.
Adjusted for age, sex, smoking status, and family history of premature CVD.
CI, confidence interval; CVD, cardiovascular disease; LV, left ventricle; LVH, left ventricle hypertrophy; MS, metabolic syndrome; OR, odds ratio.